Significant responses to platinum-based chemotherapy in renal medullary carcinoma

John J. Strouse; Melissa Spevak; A. Kyle Mack; Robert J. Arceci; Donald Small; David M. Loeb

doi:10.1002/pbc.20292

Significant responses to platinum-based chemotherapy in renal medullary carcinoma

John J. Strouse, Melissa Spevak, A. Kyle Mack, Robert J. Arceci, Donald Small, David M. Loeb

School of Medicine

Research output: Contribution to journal › Article › peer-review

40 Scopus citations

Abstract

Most patients with renal medullary carcinoma (RMC) have advanced disease at presentation and rarely respond to radiation or chemotherapy. We describe two adolescents with metastatic disease who had significant responses to cisplatin or carboplatin in combination with gemcitabine and paclitaxel.

Original language	English (US)
Pages (from-to)	407-411
Number of pages	5
Journal	Pediatric Blood and Cancer
Volume	44
Issue number	4
DOIs	https://doi.org/10.1002/pbc.20292
State	Published - Apr 2005

Keywords

Chemotherapy
Renal medullary carcinoma
Sickle cell trait

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Hematology
Oncology

Access to Document

10.1002/pbc.20292

Cite this

@article{f8433e5b24624b56a335e194f161cb81,

title = "Significant responses to platinum-based chemotherapy in renal medullary carcinoma",

abstract = "Most patients with renal medullary carcinoma (RMC) have advanced disease at presentation and rarely respond to radiation or chemotherapy. We describe two adolescents with metastatic disease who had significant responses to cisplatin or carboplatin in combination with gemcitabine and paclitaxel.",

keywords = "Chemotherapy, Renal medullary carcinoma, Sickle cell trait",

author = "Strouse, {John J.} and Melissa Spevak and Mack, {A. Kyle} and Arceci, {Robert J.} and Donald Small and Loeb, {David M.}",

year = "2005",

month = apr,

doi = "10.1002/pbc.20292",

language = "English (US)",

volume = "44",

pages = "407--411",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "4",

}

TY - JOUR

T1 - Significant responses to platinum-based chemotherapy in renal medullary carcinoma

AU - Strouse, John J.

AU - Spevak, Melissa

AU - Mack, A. Kyle

AU - Arceci, Robert J.

AU - Small, Donald

AU - Loeb, David M.

PY - 2005/4

Y1 - 2005/4

N2 - Most patients with renal medullary carcinoma (RMC) have advanced disease at presentation and rarely respond to radiation or chemotherapy. We describe two adolescents with metastatic disease who had significant responses to cisplatin or carboplatin in combination with gemcitabine and paclitaxel.

AB - Most patients with renal medullary carcinoma (RMC) have advanced disease at presentation and rarely respond to radiation or chemotherapy. We describe two adolescents with metastatic disease who had significant responses to cisplatin or carboplatin in combination with gemcitabine and paclitaxel.

KW - Chemotherapy

KW - Renal medullary carcinoma

KW - Sickle cell trait

UR - http://www.scopus.com/inward/record.url?scp=14644422605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14644422605&partnerID=8YFLogxK

U2 - 10.1002/pbc.20292

DO - 10.1002/pbc.20292

M3 - Article

C2 - 15602719

AN - SCOPUS:14644422605

SN - 1545-5009

VL - 44

SP - 407

EP - 411

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 4

ER -

Significant responses to platinum-based chemotherapy in renal medullary carcinoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this